Detalhe da pesquisa
1.
Effect of Cytomegalovirus Reactivation With or Without Acute Graft-Versus-Host Disease on the Risk of Nonrelapse Mortality.
Clin Infect Dis
; 73(3): e620-e628, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33341890
2.
Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD.
Cell Immunol
; 367: 104410, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274730
3.
Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation.
Br J Clin Pharmacol
; 86(12): 2464-2472, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386102
4.
Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.
Am J Hematol
; 98(9): E251-E254, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381699
5.
Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis.
Blood Adv
; 7(1): 106-121, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468620
6.
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial.
Hematology
; 27(1): 239-248, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35152852
7.
GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.
Bone Marrow Transplant
; 56(1): 155-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665675
8.
Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.
Bone Marrow Transplant
; 56(1): 298, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843726
9.
Hairy Cell Leukemia with Systemic Lymphadenopathy: Detection of BRAF Mutations in Both Lymph Node and Peripheral Blood Specimens.
Intern Med
; 54(11): 1397-402, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027995